In particular, we reported that in patients affected by CCD, an autosomal dominant inherited skeletal disease, RUNX2 mutations impair osteogenic differentiation (Dalle Carbonare et al., 2021). This evidence concerns the gene RUNX2 and cleidocranial dysplasia 1.